Controversial commencement speaker Jonathan Haidt urges graduates to delete social media apps on their phones and invest in real-world relationships.
SpaceX, OpenAI and Anthropic are all anticipated to go public this year, starting with Elon Musk’s rocket company this summer. These three deals alone represent some of the biggest of all time—if their billionaire CEOs can pull them off. Join Forbes ex…
Investor Kenneth Hao’s $100 million gift to UCSF targets AI and collaboration. But he warns philanthropists can’t solve all of higher education’s funding challenges.
The next-gen chipmaker first filed for its IPO in September 2024. Now, after snags that held up its debut, it’s a public company.
The government argues it needs user data to prosecute EZ Lynk for allegedly willfully helping users break emissions laws (which the company denies). But it looks like unnecessary overreach.
How Scale AI Is Adapting Post Meta Deal And Founder’s Departure
The initial public offerings for SpaceX, OpenAI and Anthropic are on track to surpass the cash VCs raked in on every other startup exit since 2016—combined.
Isomorphic, which formed as an Alphabet company in 2021, has a massive cash horde, but it’s tight-lipped on what drugs it might bring to the clinic.
In this week’s edition of InnovationRx, we look at the latest on the hantavirus outbreak, using quantum physics for metabolic MRIs, how AI can help fill prescriptions and more.
NVision raises $38 million led by health diagnostics giant Abbott to scale up its groundbreaking cancer imaging system. Next up: using its quantum technology to design new drugs.